Not Signed In - Clexane (REG) / Lovenox (REG) More Effective For Preventing Venous Thromboembolism In Patients With Acute Ischemic Stroke
Sat, 16 Dec 2006 03:00 PM EST
... Sanofi-aventis has announced that the results of the PREVAIL (Prevention of VTE after Acute Ischemic Stroke with LMWH Enoxaparin) study presented at the 48th American Society of Hematology (ASH) annual meeting in Orlando demonstrated a significant 43% reduction in venous thromboembolism (VTE) events with enoxaparin vs. [click link for full article] ...
Related Topics
- Enoxaparin Injection
- Mini-Strokes
- Venous Thrombosis
- Stroke
- WISE EARS!® At Work!
- WISE EARS!® Campaign to Prevent NIHL
- WISE EARS!® Tips: Hearing Matters
- Stroke, Transient
- Acute Care
- Ischemic Heart Disease
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- Venous Leg Ulcers
- Heart Attack
- Acute Coronary Syndrome
- Spasticity
- Leukemia
- Colitis
- Encephalopathy
email this page
print this page
bookmark this page
feedback on this page
